1. Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis

   • Isla S. Mackenzie
   • Li Wei
   • Thomas M. MacDonald

   Review Article Open access 26 June 2012 Pages: 133 - 141

   

2. Pharmacokinetics of transdermal buprenorphine patch in the elderly

   • Nabil Al-Tawil
   • Ingegerd Odar-Cederlöf
   • Jan Persson

   Clinical Trial Open access 17 June 2012 Pages: 143 - 149

   

3. Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials

   • Yong-Ying Xiao
   • Ping Zhan
   • Yi Shi

   Clinical Trial 24 June 2012 Pages: 151 - 159

   

4. Evaluating the effects of diclofenac sodium and etodolac on renal hemodynamics with contrast-enhanced ultrasonography: a pilot study

   • Hiroshi Imamura
   • Jiro Hata
   • Ken Haruma

   Clinical Trial 26 June 2012 Pages: 161 - 165

   

5. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril

   • P. S. Silva
   • V. Fontana
   • J. E. Tanus-Santos

   Pharmacogenetics 17 June 2012 Pages: 167 - 177

   

6. Drug–drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers

   • Jia Wu
   • Li-Tao Jia
   • Jian-Ting Cai

   Pharmacogenetics 16 June 2012 Pages: 179 - 187

   

7. Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients

   • Wei Zhao
   • May Fakhoury
   • Evelyne Jacqz-Aigrain

   Pharmacogenetics 17 June 2012 Pages: 189 - 195

   

8. High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension

   • A. M. Sandqvist
   • D. Henrohn
   • B. G. Wikström

   Pharmacokinetics and Disposition 26 June 2012 Pages: 197 - 207

   

9. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study

   • Linda Härmark
   • Eugène van Puijenbroek
   • Kees van Grootheest

   Pharmacoepidemiology and Prescription Open access 12 June 2012 Pages: 209 - 215

   

10. The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals

    • Hans C. Ebbers
    • Aukje K. Mantel-Teeuwisse
    • Hubert G. M. Leufkens

    Pharmacoepidemiology and Prescription Open access 17 June 2012 Pages: 217 - 226

    

11. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care

    • Gianluca Trifirò
    • Silvia Tillati
    • Fabio Samani

    Pharmacoepidemiology and Prescription 17 June 2012 Pages: 227 - 236

    

12. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region)

    • Chiara Biagi
    • Nicola Montanaro
    • Domenico Motola

    Pharmacoepidemiology and Prescription 17 June 2012 Pages: 237 - 244

    

13. Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors’ adherence to warfarin therapy recommendations

    • Axel C. Carlsson
    • Per Wändell
    • Jan Sundquist

    Pharmacoepidemiology and Prescription 10 June 2012 Pages: 245 - 253

14. Improvement in the detection of adverse drug events by the use of electronic health and prescription records: An evaluation of two trigger tools

    • Ugochi Nwulu
    • Krishnarajah Nirantharakumar
    • Jamie J. Coleman

    Pharmacoepidemiology and Prescription 17 June 2012 Pages: 255 - 259

    

15. Statin use among older Finns stratified according to cardiovascular risk

    • Eveliina Upmeier
    • Maarit Jaana Korhonen
    • Risto Huupponen

    Pharmacoepidemiology and Prescription 17 June 2012 Pages: 261 - 267

    

16. Safety of ginger use in pregnancy: results from a large population-based cohort study

    • Kristine Heitmann
    • Hedvig Nordeng
    • Lone Holst

    Pharmacoepidemiology and Prescription 17 June 2012 Pages: 269 - 277

17. Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study

    • Per Wändell
    • Axel C. Carlsson
    • Jan Sundquist

    Pharmacoepidemiology and Prescription 19 September 2012 Pages: 279 - 287

18. Case series: paradoxical action of domperidone leads to increased vomiting

    • Marco Pozzi
    • Sandra Strazzer
    • Sonia Radice

    Letter to the Editors 16 June 2012 Pages: 289 - 290

19. Administration of tramadol or ibuprofen increases the INR level in patients on warfarin

    • Jacob Juel
    • Torben Brøchner Pedersen
    • Svend Eggert Jensen

    Letter to the Editors 17 June 2012 Pages: 291 - 292

    

20. Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy

    • Tejasvita Gaikwad
    • Kanjaksha Ghosh
    • Shrimati Shetty

    Letter to the Editors 17 June 2012 Pages: 293 - 294